BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

395 related articles for article (PubMed ID: 29275360)

  • 1. The Role of micro RNAs in Breast Cancer Metastasis: Preclinical Validation and Potential Therapeutic Targets.
    Weidle UH; Dickopf S; Hintermair C; Kollmorgen G; Birzele F; Brinkmann U
    Cancer Genomics Proteomics; 2018; 15(1):17-39. PubMed ID: 29275360
    [TBL] [Abstract][Full Text] [Related]  

  • 2. microRNAs and Corresponding Targets Involved in Metastasis of Colorectal Cancer in Preclinical
    Weidle UH; Brinkmann U; Auslaender S
    Cancer Genomics Proteomics; 2020; 17(5):453-468. PubMed ID: 32859626
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD103-positive CSC exosome promotes EMT of clear cell renal cell carcinoma: role of remote MiR-19b-3p.
    Wang L; Yang G; Zhao D; Wang J; Bai Y; Peng Q; Wang H; Fang R; Chen G; Wang Z; Wang K; Li G; Yang Y; Wang Z; Guo P; Peng L; Hou D; Xu W
    Mol Cancer; 2019 Apr; 18(1):86. PubMed ID: 30975145
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exosomes of Mesenchymal Stem Cells as a Proper Vehicle for Transfecting miR-145 into the Breast Cancer Cell Line and Its Effect on Metastasis.
    Sheykhhasan M; Kalhor N; Sheikholeslami A; Dolati M; Amini E; Fazaeli H
    Biomed Res Int; 2021; 2021():5516078. PubMed ID: 34307654
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Functional Role of Prostate Cancer Metastasis-related Micro-RNAs.
    Weidle UH; Epp A; Birzele F; Brinkmann U
    Cancer Genomics Proteomics; 2019; 16(1):1-19. PubMed ID: 30587496
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mesenchymal stem cell-derived exosomes enriched with miR-218 reduce the epithelial-mesenchymal transition and angiogenesis in triple-negative breast cancer cells.
    Shojaei S; Moradi-Chaleshtori M; Paryan M; Koochaki A; Sharifi K; Mohammadi-Yeganeh S
    Eur J Med Res; 2023 Nov; 28(1):516. PubMed ID: 37968694
    [TBL] [Abstract][Full Text] [Related]  

  • 7. microRNA-21 promotes breast cancer proliferation and metastasis by targeting LZTFL1.
    Wang H; Tan Z; Hu H; Liu H; Wu T; Zheng C; Wang X; Luo Z; Wang J; Liu S; Lu Z; Tu J
    BMC Cancer; 2019 Jul; 19(1):738. PubMed ID: 31351450
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of cell growth and migration by miR-96 and miR-183 in a breast cancer model of epithelial-mesenchymal transition.
    Anderson O; Guttilla Reed IK
    PLoS One; 2020; 15(5):e0233187. PubMed ID: 32396572
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNAs Involved in Metastasis of Hepatocellular Carcinoma: Target Candidates, Functionality and Efficacy in Animal Models and Prognostic Relevance.
    Weidle UH; Schmid D; Birzele F; Brinkmann U
    Cancer Genomics Proteomics; 2020; 17(1):1-21. PubMed ID: 31882547
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNA-34a targets epithelial to mesenchymal transition-inducing transcription factors (EMT-TFs) and inhibits breast cancer cell migration and invasion.
    Imani S; Wei C; Cheng J; Khan MA; Fu S; Yang L; Tania M; Zhang X; Xiao X; Zhang X; Fu J
    Oncotarget; 2017 Mar; 8(13):21362-21379. PubMed ID: 28423483
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exosome-mediated miR-200a delivery into TGF-β-treated AGS cells abolished epithelial-mesenchymal transition with normalization of ZEB1, vimentin and Snail1 expression.
    Mirzaei S; Gholami MH; Aghdaei HA; Hashemi M; Parivar K; Karamian A; Zarrabi A; Ashrafizadeh M; Lu J
    Environ Res; 2023 Aug; 231(Pt 1):116115. PubMed ID: 37178752
    [TBL] [Abstract][Full Text] [Related]  

  • 12. miR-300 inhibits epithelial to mesenchymal transition and metastasis by targeting Twist in human epithelial cancer.
    Yu J; Xie F; Bao X; Chen W; Xu Q
    Mol Cancer; 2014 May; 13():121. PubMed ID: 24885626
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Breast cancer-derived exosomes regulate cell invasion and metastasis in breast cancer via miR-146a to activate cancer associated fibroblasts in tumor microenvironment.
    Yang SS; Ma S; Dou H; Liu F; Zhang SY; Jiang C; Xiao M; Huang YX
    Exp Cell Res; 2020 Jun; 391(2):111983. PubMed ID: 32268136
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of microRNAs in endocrine cancer metastasis.
    Lima CR; Gomes CC; Santos MF
    Mol Cell Endocrinol; 2017 Nov; 456():62-75. PubMed ID: 28322989
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potential microRNA-related Targets for Therapeutic Intervention with Ovarian Cancer Metastasis.
    Weidle UH; Birzele F; Kollmorgen G; Nopora A
    Cancer Genomics Proteomics; 2018; 15(1):1-15. PubMed ID: 29275359
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cancer-associated fibroblasts release exosomal microRNAs that dictate an aggressive phenotype in breast cancer.
    Donnarumma E; Fiore D; Nappa M; Roscigno G; Adamo A; Iaboni M; Russo V; Affinito A; Puoti I; Quintavalle C; Rienzo A; Piscuoglio S; Thomas R; Condorelli G
    Oncotarget; 2017 Mar; 8(12):19592-19608. PubMed ID: 28121625
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cancer-associated fibroblast-derived exosomal miR-18b promotes breast cancer invasion and metastasis by regulating TCEAL7.
    Yan Z; Sheng Z; Zheng Y; Feng R; Xiao Q; Shi L; Li H; Yin C; Luo H; Hao C; Wang W; Zhang B
    Cell Death Dis; 2021 Dec; 12(12):1120. PubMed ID: 34853307
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Down-regulation of MicroRNAs (MiRs) 203, 887, 3619 and 182 Prevents Vimentin-triggered, Phospholipase D (PLD)-mediated Cancer Cell Invasion.
    Fite K; Gomez-Cambronero J
    J Biol Chem; 2016 Jan; 291(2):719-30. PubMed ID: 26567912
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNAs and gene regulation in breast cancer.
    Abdalla F; Singh B; Bhat HK
    J Biochem Mol Toxicol; 2020 Nov; 34(11):e22567. PubMed ID: 32729651
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exosomal miR-1255b-5p targets human telomerase reverse transcriptase in colorectal cancer cells to suppress epithelial-to-mesenchymal transition.
    Zhang X; Bai J; Yin H; Long L; Zheng Z; Wang Q; Chen F; Yu X; Zhou Y
    Mol Oncol; 2020 Oct; 14(10):2589-2608. PubMed ID: 32679610
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.